These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23302227)

  • 1. Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer.
    Tahir SA; Yang G; Goltsov A; Song KD; Ren C; Wang J; Chang W; Thompson TC
    Cancer Res; 2013 Mar; 73(6):1900-11. PubMed ID: 23302227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
    Lu W; Lin C; Li Y
    Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
    Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
    Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells.
    Palozza P; Sestito R; Picci N; Lanza P; Monego G; Ranelletti FO
    Carcinogenesis; 2008 Nov; 29(11):2153-61. PubMed ID: 18635524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel actin cytoskeleton-dependent noncaveolar microdomain composed of homo-oligomeric caveolin-2 for activation of insulin signaling.
    Kwon H; Lee J; Jeong K; Jang D; Pak Y
    Biochim Biophys Acta; 2013 Oct; 1833(10):2176-89. PubMed ID: 23665048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts.
    Salani B; Briatore L; Garibaldi S; Cordera R; Maggi D
    Endocrinology; 2008 Feb; 149(2):461-5. PubMed ID: 18039791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
    Bennett NC; Hooper JD; Johnson DW; Gobe GC
    Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states.
    Hu L; Xu X; Li Q; Chen X; Yuan X; Qiu S; Yao C; Zhang D; Wang F
    FASEB J; 2021 Aug; 35(8):e21826. PubMed ID: 34320244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
    Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
    Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells.
    Salani B; Passalacqua M; Maffioli S; Briatore L; Hamoudane M; Contini P; Cordera R; Maggi D
    PLoS One; 2010 Nov; 5(11):e14157. PubMed ID: 21152401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo.
    Bartz R; Zhou J; Hsieh JT; Ying Y; Li W; Liu P
    Int J Cancer; 2008 Feb; 122(3):520-5. PubMed ID: 17943731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yang G; Goltsov AA; Ren C; Kurosaka S; Edamura K; Logothetis R; DeMayo FJ; Troncoso P; Blando J; DiGiovanni J; Thompson TC
    Mol Cancer Res; 2012 Feb; 10(2):218-29. PubMed ID: 22144662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.
    Tahir SA; Park S; Thompson TC
    Cancer Biol Ther; 2009 Dec; 8(23):2286-96. PubMed ID: 19923922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
    Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
    J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling.
    Hamoudane M; Maffioli S; Cordera R; Maggi D; Salani B
    J Endocrinol Invest; 2013 Mar; 36(3):204-8. PubMed ID: 23404184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt co-receptor low density lipoprotein receptor-related protein-5 (LRP5).
    Palsgaard J; Emanuelli B; Winnay JN; Sumara G; Karsenty G; Kahn CR
    J Biol Chem; 2012 Apr; 287(15):12016-26. PubMed ID: 22337886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.
    Tahir SA; Kurosaka S; Tanimoto R; Goltsov AA; Park S; Thompson TC
    Cancer Biol Ther; 2013 Feb; 14(2):117-26. PubMed ID: 23114714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.